Loading...
Statistics
Advertisement

LAZSKO.eu
www.lazsko.eu/
Obec Lazsko

Lazsko.eu

Advertisement
Conversion Technology Metas Server
Lazsko.eu is hosted in Czech Republic / Prague . Lazsko.eu uses HTTPS protocol. Number of used technologies: 3. First technologies: CSS, Html, Javascript, Number of used javascripts: 4. First javascripts: Prototype.js, Scriptaculous.js, Lightbox.js, Number of used analytics tools: 0. Its server type is: Apache.

Technologies in use by Lazsko.eu

Technology

Number of occurences: 3
  • CSS
  • Html
  • Javascript

Advertisement

Javascripts

Number of occurences: 4
  • prototype.js
  • scriptaculous.js
  • lightbox.js
  • iepngfix_tilebg.js

Server Type

  • Apache

Powered by

  • PleskLin

Conversion rate optimization
visitors Clickable call number Not founded!
visitors Conversion form (contact form, subcriber) Not founded!
visitors Clickable email Not founded!
visitors CTA (call to action) button Not founded!
visitors List Not founded!
visitors Image Not founded!
visitors Enhancement Not founded!
visitors Responsive website Not founded!
visitors Facebook sharing Not founded!
visitors Google+ sharing Not founded!
visitors Twitter sharing Not founded!
visitors Linkedin sharing Not founded!
visitors Blog on the webiste Not founded!

HTTPS (SSL) - Lazsko.eu

SSL certificate

    • name: /OU=Domain Control Validated/OU=PositiveSSL Wildcard/CN=*.orsys.cz
    • subject:
      • OU:
        • 0: Domain Control Validated
        • 1: PositiveSSL Wildcard
      • CN: *.orsys.cz
    • hash: 9d593f40
    • issuer:
      • C: GB
      • ST: Greater Manchester
      • L: Salford
      • O: COMODO CA Limited
      • CN: COMODO RSA Domain Validation Secure Server CA
    • version: 2
    • serialNumber: 217977691844155579879176216544645661674
    • validFrom: 160407000000Z
    • validTo: 170407235959Z
    • validFrom_time_t: 1459987200
    • validTo_time_t: 1491609599
    • extensions:
      • authorityKeyIdentifier: keyid:90:AF:6A:3A:94:5A:0B:D8:90:EA:12:56:73:DF:43:B4:3A:28:DA:E7
      • subjectKeyIdentifier: 9F:A3:98:82:B5:19:F5:81:E8:83:5C:59:7A:F6:95:13:A9:49:FE:B7
      • keyUsage: Digital Signature, Key Encipherment
      • basicConstraints: CA:FALSE
      • extendedKeyUsage: TLS Web Server Authentication, TLS Web Client Authentication
      • certificatePolicies: Policy: 1.3.6.1.4.1.6449.1.2.2.7 CPS: https://secure.comodo.com/CPS Policy: 2.23.140.1.2.1
      • crlDistributionPoints: Full Name: URI:http://crl.comodoca.com/COMODORSADomainValidationSecureServerCA.crl
      • authorityInfoAccess: CA Issuers - URI:http://crt.comodoca.com/COMODORSADomainValidationSecureServerCA.crt OCSP - URI:http://ocsp.comodoca.com
      • subjectAltName: DNS:*.orsys.cz, DNS:orsys.cz

Meta - Lazsko.eu

Number of occurences: 5
  • Name:
    Content: application/xhtml+xml; charset=utf-8
  • Name: description
    Content: Obec Lazsko
  • Name: keywords
    Content: obec lazsko hasici
  • Name: author
    Content: ORSYS s.r.o. // e-services solutions
  • Name: robots
    Content: ALL,FOLLOW

Server / Hosting

  • IP: 78.24.14.186
  • Latitude: 50.08
  • Longitude: 14.47
  • Country: Czech Republic
  • City: Prague

Rname

  • orsys.vshosting.cz
  • ns2.vshosting.cz
  • mail.lazsko.eu

Target

  • admin.orsys.cz

HTTP Header Response

HTTP/1.1 302 Found Date: Thu, 30 Jun 2016 21:39:58 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Set-Cookie: appwebrootindexphp=niq6idcf926vnedqdgoeh6pv41; path=/ Location: /cze/index.html X-Powered-By: PleskLin Content-Type: text/html; charset=UTF-8 X-Cache: MISS from s_xt27 X-Cache-Lookup: MISS from s_xt27:80 Via: 1.1 s_xt27 (squid/3.5.6) Connection: keep-alive HTTP/1.1 200 OK Date: Thu, 30 Jun 2016 21:39:58 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Set-Cookie: appwebrootindexphp=8o86m1r8m5rmdek9ur1q7ab1j6; path=/ X-Powered-By: PleskLin Content-Type: text/html; charset=UTF-8 X-Cache: MISS from s_xt27 X-Cache-Lookup: MISS from s_xt27:80 Via: 1.1 s_xt27 (squid/3.5.6) Connection: keep-alive

DNS

host: lazsko.eu
  1. class: IN
  2. ttl: 86400
  3. type: A
  4. ip: 78.24.14.186
host: lazsko.eu
  1. class: IN
  2. ttl: 86400
  3. type: NS
  4. target: orsys.vshosting.cz
host: lazsko.eu
  1. class: IN
  2. ttl: 86400
  3. type: NS
  4. target: ns2.vshosting.cz
host: lazsko.eu
  1. class: IN
  2. ttl: 86400
  3. type: SOA
  4. mname: ns2.vshosting.cz
  5. rname: admin.orsys.cz
  6. serial: 2016050201
  7. refresh: 10800
  8. retry: 3600
  9. expire: 604800
  10. minimum-ttl: 10800
host: lazsko.eu
  1. class: IN
  2. ttl: 86400
  3. type: MX
  4. pri: 10
  5. target: mail.lazsko.eu
host: lazsko.eu
  1. class: IN
  2. ttl: 86400
  3. type: TXT
  4. txt: v=spf1 +a +mx -all +a:orsys.vshosting.cz
  5. entries: Array

Common Typos/Mistakes

This list shows You some spelling mistakes at internet search for this domain.

www.azsko.eu, www.luazsko.eu, www.uazsko.eu, www.l8azsko.eu, www.8azsko.eu, www.l9azsko.eu, www.9azsko.eu, www.ljazsko.eu, www.jazsko.eu, www.l0azsko.eu, www.0azsko.eu, www.lmazsko.eu, www.mazsko.eu, www.lpazsko.eu, www.pazsko.eu, www.loazsko.eu, www.oazsko.eu, www.lzsko.eu, www.laozsko.eu, www.lozsko.eu, www.lapzsko.eu, www.lpzsko.eu, www.la9zsko.eu, www.l9zsko.eu, www.lazsko.eu, www.lzsko.eu, www.laizsko.eu, www.lizsko.eu, www.lauzsko.eu, www.luzsko.eu, www.lasko.eu, www.laztsko.eu, www.latsko.eu, www.lazasko.eu, www.laasko.eu, www.lazssko.eu, www.lassko.eu, www.lazxsko.eu, www.laxsko.eu, www.lazcsko.eu, www.lacsko.eu, www.lazgsko.eu, www.lagsko.eu, www.lazhsko.eu, www.lahsko.eu, www.lazjsko.eu, www.lajsko.eu, www.lazusko.eu, www.lausko.eu, www.lazko.eu, www.lazseko.eu, www.lazeko.eu, www.lazswko.eu, www.lazwko.eu, www.lazsdko.eu, www.lazdko.eu, www.lazsxko.eu, www.lazxko.eu, www.lazsfko.eu, www.lazfko.eu, www.lazsgko.eu, www.lazgko.eu, www.lazstko.eu, www.laztko.eu, www.lazso.eu, www.lazskto.eu, www.lazsto.eu, www.lazsko.eu, www.lazso.eu, www.lazskgo.eu, www.lazsgo.eu, www.lazskbo.eu, www.lazsbo.eu, www.lazskno.eu, www.lazsno.eu, www.lazskho.eu, www.lazsho.eu, www.lazskyo.eu, www.lazsyo.eu, www.lazsklo.eu, www.lazslo.eu, www.lazskoo.eu, www.lazsoo.eu, www.lazskuo.eu, www.lazsuo.eu, www.lazskio.eu, www.lazsio.eu, www.lazskmo.eu, www.lazsmo.eu, www.lazsk.eu, www.lazskob.eu, www.lazskb.eu, www.lazskoh.eu, www.lazskh.eu, www.lazskog.eu, www.lazskg.eu, www.lazskoj.eu, www.lazskj.eu, www.lazskom.eu, www.lazskm.eu, www.lazsko .eu, www.lazsk .eu, www.lazskov.eu, www.lazskv.eu,

Other websites we recently analyzed

  1. Prairie Sun Farm
    Scottsdale (United States) - 184.168.193.35
    Server software: Microsoft-IIS/7.0
    Technology: CSS, Html
    Number of meta tags: 1
  2. Home » Bring to Light Photography Blog
    Boston Baby and Child Photographer Taslim Sidi
    Provo (United States) - 69.89.18.39
    Server software: Apache
    Technology: BootstrapCDN, CSS, Font Awesome, Google Font API, Html, Html5, Javascript, jQuery, Php, Pingback, StatCounter, Wordpress
    Number of Javascript: 6
    Number of meta tags: 4
  3. 麦光商城
    专业的企事业单位设备供应销售平台
    Hangzhou (China) - 139.129.150.202
    Server software: Apache
    Technology: CSS, Html, Javascript, Php
    Number of Javascript: 5
    Number of meta tags: 4
  4. Home
    Scottsdale (United States) - 72.167.191.69
    Server software: DPS/1.0.6
    Technology: CSS, Html, Html5, Javascript
    Number of Javascript: 1
    Number of meta tags: 2
  5. Эксклюзивное столярное производство | ИП Степкин В.И.
    сайт www.StepkinSV.ru Славянск-на-Кубани
    Russian Federation - 81.177.32.14
    Server software: Apache
    Technology: CSS, Html, Javascript, Php
    Number of Javascript: 2
    Number of meta tags: 10
  6. Unified Messaging Systeme
    Berlin (Germany) - 81.169.145.83
    Server software: Apache/2.2.31 (Unix)
    Technology: CSS, Html, Javascript, Php
    Number of Javascript: 2
    Number of meta tags: 4
  7. annagenoese.com
    Brea (United States) - 69.163.217.123
    Server software: Apache
    Technology: Html, Javascript
    Number of meta tags: 1
  8. Welcome to MYLEX12.COM
    Scottsdale (United States) - 184.168.221.96
    Server software: Microsoft-IIS/7.5
    Technology: Google Adsense, CSS, Html, Javascript
    Number of Javascript: 3
    Number of meta tags: 1
  9. pulmicortturbuhaler.sg
    Wilmington (United States) - 165.160.15.20
    Server software:
    Technology: Html
    Number of meta tags: 1
  10. About GAZYVA® (obinutuzumab) Treatment
    Learn about GAZYVA® in relapsed/refractory follicular lymphoma, and previously untreated chronic lymphocytic leukemia treatment. Indication GAZYVA (R) (obinutuzumab) is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous CLL treatment. GAZYVA (R) (obinutuzumab) is a prescription medicine used with the chemotherapy drug, bendamustine, followed by GAZYVA alone for follicular lymphoma (FL) in adults who did not respond to a rituximab-containing regimen, or whose FL return after such treatment. IMPORTANT SAFETY INFORMATION What is the most important safety information I should know about GAZYVA? Tell your doctor right away about any side effect you experience. GAZYVA can cause side effects that can become serious or life threatening, including: - Hepatitis B Virus (HBV): Hepatitis B can cause liver failure and death. If you have a history of hepatitis B infection, GAZYVA could cause it to return. You should not receive GAZYVA if you have active hepatitis B liver disease. Your doctor or healthcare team will need to screen you for hepatitis B before, and monitor you during and after, your treatment with GAZYVA. Sometimes this will require treatment for hepatitis B. Symptoms of hepatitis include: worsening of fatigue and yellow discoloration of skin or eyes - Progressive Multifocal Leukoencephalopathy (PML): PML is a rare and serious brain infection caused by a virus. PML can be fatal. Your weakened immune system could put you at risk. Your doctor will watch for symptoms. Symptoms of PML include: confusion, difficulty talking or walking, dizziness or loss of balance, and vision problems What are the additional possible serious side effects of GAZYVA? Tell your doctor right away about any side effect you experience. GAZYVA can cause side effects that may become severe or life threatening, including: - Infusion Reactions: These side effects may occur during or within 24 hours of any GAZYVA infusion. Some infusion reactions can be serious, including, but not limited to, severe allergic reactions (anaphylaxis), acute life-threatening breathing problems, or other life-threatening infusion reactions. If you have a reaction, the infusion is either slowed or stopped until your symptoms are resolved - Most patients are able to complete infusions and receive medication again. However, if the infusion reaction is serious, the infusion of GAZYVA will be permanently stopped. Your healthcare team will take steps to help lessen any side effects you may have to the infusion process. You may be given medicines to take before each GAZYVA treatment. Signs of infusion reactions may include: tiredness, dizziness, headache, redness of the face, nausea, chills, fever, vomiting, diarrhea, breathing problems, and chest pain - Tumor Lysis Syndrome (TLS): Tumor lysis syndrome, including fatal cases, has been reported in patients receiving GAZYVA. GAZYVA works to break down cancer cells quickly. As cancer cells break apart, their contents are released into the blood. These contents may cause damage to organs and the heart, and may lead to kidney failure requiring the need for dialysis treatment. Your doctor may prescribe medication to help prevent TLS. Your doctor will also conduct regular blood tests to check for TLS. Symptoms of TLS may include nausea, vomiting, diarrhea, and tiredness - Infections: While you're taking GAZYVA, you may develop infections. Some of these infections may be severe. Fatal infections have been reported with GAZYVA, so be sure to talk to your doctor if you think you have one. Patients with active infection should not be treated with GAZYVA. Your risk for infections may continue even after you stop taking GAZYVA. Your doctor may prescribe medications to help prevent infections. Symptoms of infection include fever and cough - Low White Blood Cell Count: When you have an abnormally low count of infection-fighting white blood cells, it is called neutropenia. While you are taking GAZYVA, your doctor will do blood work to check your white blood cell count. Severe and life-threatening neutropenia can develop during or after treatment with GAZYVA. Some cases of neutropenia can last for more than one month. If your white blood cell count is low, your doctor may prescribe medication to help prevent infections - Low Platelet Count: Platelets help stop bleeding or blood loss. GAZYVA may reduce the number of platelets you have in your blood; having low platelet count is called thrombocytopenia. This may affect the clotting process. While you are taking GAZYVA, your doctor will do blood work to check your platelet count. Severe and life-threatening thrombocytopenia can develop during or after treatment with GAZYVA. If your platelet count gets too low, your treatment may be delayed or reduced - The most common side effects of GAZYVA in CLL are infusion reactions, low white blood cell counts, low platelet counts, low red blood cell counts, fever, cough, nausea, and diarrhea. - The safety of GAZYVA was evaluated based on 392 patients with indolent NHL (iNHL) of whom 81% had follicular lymphoma. In patients with follicular lymphoma, the most common side effects that were seen were consistent with the overall population who had iNHL. The most common side effects of GAZYVA in iNHL are infusion reactions, low white blood cell counts, nausea, fatigue, cough, diarrhea, constipation, fever, low platelet counts, vomiting, upper respiratory tract infection, decreased appetite, joint or muscle pain, sinusitis, low red blood cell counts, general weakness, and urinary tract infection. What other information should I tell my doctor before receiving GAZYVA? You should talk to your doctor about: - Immunizations: Before receiving GAZYVA therapy, tell your healthcare provider if you have recently received or are scheduled to receive a vaccine. People who are treated with GAZYVA should not receive live vaccines - Pregnancy: Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. GAZYVA may harm your unborn baby. Speak to your doctor about using GAZYVA while you are pregnant. Talk to your doctor or your child's doctor about the safety and timing of live virus vaccinations to your infant if you received GAZYVA during pregnancy. It is not known if GAZYVA may pass into your breast milk. Speak to your doctor about using GAZYVA if you are breastfeeding Tell your doctor about any side effects.These are not all of the possible side effects of GAZYVA. For more information, ask your doctor or pharmacist. GAZYVA is available by prescription only. You may report side effects to the FDA at (800) FDA-1088, or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the accompanying full Prescribing Information, including Boxed WARNINGS, for additional Important Safety Information.Indication GAZYVA (R) (obinutuzumab) is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous CLL treatment. GAZYVA (R) (obinutuzumab) is a prescription medicine used with the chemotherapy drug, bendamustine, followed by GAZYVA alone for follicular lymphoma (FL) in adults who did not respond to a rituximab-containing regimen, or whose FL return after such treatment. IMPORTANT SAFETY INFORMATION What is the most important safety information I should know about GAZYVA? Tell your doctor right away about any side effect you experience. GAZYVA can cause side effects that can become serious or life threatening, including: - Hepatitis B Virus (HBV): Hepatitis B can cause liver failure and death. If you have a history of hepatitis B infection, GAZYVA could cause it to return. You should not receive GAZYVA if you have active hepatitis B liver disease. Your doctor or healthcare team will need to screen you for hepatitis B before, and monitor you during and after, your treatment with GAZYVA. Sometimes this will require treatment for hepatitis B. Symptoms of hepatitis include: worsening of fatigue and yellow discoloration of skin or eyes - Progressive Multifocal Leukoencephalopathy (PML): PML is a rare and serious brain infection caused by a virus. PML can be fatal. Your weakened immune system could put you at risk. Your doctor will watch for symptoms. Symptoms of PML include: confusion, difficulty talking or walking, dizziness or loss of balance, and vision problems What are the additional possible serious side effects of GAZYVA? Tell your doctor right away about any side effect you experience. GAZYVA can cause side effects that may become severe or life threatening, including: - Infusion Reactions: These side effects may occur during or within 24 hours of any GAZYVA infusion. Some infusion reactions can be serious, including, but not limited to, severe allergic reactions (anaphylaxis), acute life-threatening breathing problems, or other life-threatening infusion reactions. If you have a reaction, the infusion is either slowed or stopped until your symptoms are resolved - Most patients are able to complete infusions and receive medication again. However, if the infusion reaction is serious, the infusion of GAZYVA will be permanently stopped. Your healthcare team will take steps to help lessen any side effects you may have to the infusion process. You may be given medicines to take before each GAZYVA treatment. Signs of infusion reactions may include: tiredness, dizziness, headache, redness of the face, nausea, chills, fever, vomiting, diarrhea, breathing problems, and chest pain - Tumor Lysis Syndrome (TLS): Tumor lysis syndrome, including fatal cases, has been reported in patients receiving GAZYVA. GAZYVA works to break down cancer cells quickly. As cancer cells break apart, their contents are released into the blood. These contents may cause damage to organs and the heart, and may lead to kidney failure requiring the need for dialysis treatment. Your doctor may prescribe medication to help prevent TLS. Your doctor will also conduct regular blood tests to check for TLS. Symptoms of TLS may include nausea, vomiting, diarrhea, and tiredness - Infections: While you're taking GAZYVA, you may develop infections. Some of these infections may be severe. Fatal infections have been reported with GAZYVA, so be sure to talk to your doctor if you think you have one. Patients with active infection should not be treated with GAZYVA. Your risk for infections may continue even after you stop taking GAZYVA. Your doctor may prescribe medications to help prevent infections. Symptoms of infection include fever and cough - Low White Blood Cell Count: When you have an abnormally low count of infection-fighting white blood cells, it is called neutropenia. While you are taking GAZYVA, your doctor will do blood work to check your white blood cell count. Severe and life-threatening neutropenia can develop during or after treatment with GAZYVA. Some cases of neutropenia can last for more than one month. If your white blood cell count is low, your doctor may prescribe medication to help prevent infections - Low Platelet Count: Platelets help stop bleeding or blood loss. GAZYVA may reduce the number of platelets you have in your blood; having low platelet count is called thrombocytopenia. This may affect the clotting process. While you are taking GAZYVA, your doctor will do blood work to check your platelet count. Severe and life-threatening thrombocytopenia can develop during or after treatment with GAZYVA. If your platelet count gets too low, your treatment may be delayed or reduced - The most common side effects of GAZYVA in CLL are infusion reactions, low white blood cell counts, low platelet counts, low red blood cell counts, fever, cough, nausea, and diarrhea. - The safety of GAZYVA was evaluated based on 392 patients with indolent NHL (iNHL) of whom 81% had follicular lymphoma. In patients with follicular lymphoma, the most common side effects that were seen were consistent with the overall population who had iNHL. The most common side effects of GAZYVA in iNHL are infusion reactions, low white blood cell counts, nausea, fatigue, cough, diarrhea, constipation, fever, low platelet counts, vomiting, upper respiratory tract infection, decreased appetite, joint or muscle pain, sinusitis, low red blood cell counts, general weakness, and urinary tract infection. What other information should I tell my doctor before receiving GAZYVA? You should talk to your doctor about: - Immunizations: Before receiving GAZYVA therapy, tell your healthcare provider if you have recently received or are scheduled to receive a vaccine. People who are treated with GAZYVA should not receive live vaccines - Pregnancy: Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. GAZYVA may harm your unborn baby. Speak to your doctor about using GAZYVA while you are pregnant. Talk to your doctor or your child's doctor about the safety and timing of live virus vaccinations to your infant if you received GAZYVA during pregnancy. It is not known if GAZYVA may pass into your breast milk. Speak to your doctor about using GAZYVA if you are breastfeeding Tell your doctor about any side effects.These are not all of the possible side effects of GAZYVA. For more information, ask your doctor or pharmacist. GAZYVA is available by prescription only. You may report side effects to the FDA at (800) FDA-1088, or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the accompanying full Prescribing Information, including Boxed WARNINGS, for additional Important Safety Information.
    South San Francisco (United States) - 72.34.128.122
    Server software: BigIP
    Technology: CSS, Html, Html5, Javascript, Google Analytics
    Number of Javascript: 1
    Number of meta tags: 4

Check Other Websites